CRISPR Therapeutics AG and Vertex Pharmaceuticals are one step closer to gaining approval for their CRISPR/Cas9 gene editing therapy for Sickle Cell Disease and beta thalassemia. An FDA Advisory ...

While there’s no shortage of startups aiming to replace Google with AI-powered search (we’re looking at you, Perplexity), a startup called Exa has a different idea: a Google for AI. Humans aren’t the ...

Exa Labs Inc., a startup with a search engine that artificial intelligence models can use to browse the web, has raised $85 million in funding. Benchmark led the Series B round. The venture capital ...

Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis by means of ex vivo clustered regularly interspaced short palindromic repeats ...